J. B. Chemicals & Pharmaceuticals Limited
National Stock Exchange of IndiaTotal Valuation
J. B. Chemicals & Pharmaceuticals Limited carries a market capitalization of 383.74B, placing it among publicly traded companies globally. Its enterprise value stands at 312.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 383.74B |
| Enterprise Value | 312.19B |
Share Statistics
J. B. Chemicals & Pharmaceuticals Limited currently has 160.56M shares outstanding.
| Shares Outstanding | 160.56M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
J. B. Chemicals & Pharmaceuticals Limited trades at a trailing price-to-earnings ratio of 45.72. The price-to-sales ratio is 7.82, and the price-to-book ratio stands at 9.70.
| PE Ratio | 45.72 |
| PS Ratio | 7.82 |
| PB Ratio | 9.70 |
| P/TBV Ratio | 11.29 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, J. B. Chemicals & Pharmaceuticals Limited trades at an EV/EBITDA multiple of 33.75 and an EV/FCF ratio of 7,523.39. The EV/Sales ratio of 7.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 33.75 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.53 |
| EV / EBITDA | 33.75 |
| EV / EBIT | 33.75 |
| EV / FCF | 7,523.39 |
Financial Position
J. B. Chemicals & Pharmaceuticals Limited maintains a current ratio of 4.92, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.09, indicating conservative leverage, while an interest coverage ratio of 166.05 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.92 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | 166.05 |
Financial Efficiency
J. B. Chemicals & Pharmaceuticals Limited posts a return on equity of 22.54 and a return on invested capital of 18.18.
| Return on Equity (ROE) | 22.54 |
| Return on Assets (ROA) | 15.35 |
| Return on Invested Capital (ROIC) | 18.18 |
| Return on Capital Employed (ROCE) | 22.56 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.14 |
Taxes
Over the trailing twelve months, J. B. Chemicals & Pharmaceuticals Limited has paid 2.43B in income taxes, reflecting an effective tax rate of 25.50.
| Income Tax | 2.43B |
| Effective Tax Rate | 25.50 |
Stock Price Statistics
J. B. Chemicals & Pharmaceuticals Limited's stock has gained approximately 46.36536% over the past 52 weeks. The 50-day moving average sits at 2,178.93, while the 200-day moving average is 1,950.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | 46.36536% |
| 50-Day Moving Average | 2,178.93 |
| 200-Day Moving Average | 1,950.17 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, J. B. Chemicals & Pharmaceuticals Limited generated 41.48B in revenue and converted that into 7.09B in net income, yielding earnings per share of 44.55. EBITDA reached 9.25B, while operating income came in at 9.25B.
| Revenue | 41.48B |
| Gross Profit | 28.52B |
| Operating Income | 9.25B |
| Pretax Income | 9.52B |
| Net Income | 7.09B |
| EBITDA | 9.25B |
| EBIT | 9.25B |
| Earnings Per Share (EPS) | 44.55 |
Balance Sheet
J. B. Chemicals & Pharmaceuticals Limited holds 12.21B in cash and equivalents against 35.89M in total debt, resulting in a net debt position of -1.10B. Total book value stands at 33.45B, with working capital of 23.18B providing operational flexibility.
| Cash & Cash Equivalents | 12.21B |
| Total Debt | 35.89M |
| Net Debt | -1.10B |
| Equity (Book Value) | 33.45B |
| Book Value Per Share | 212.87 |
| Working Capital | 23.18B |
Margins
J. B. Chemicals & Pharmaceuticals Limited operates with a gross margin of 68.75, reflecting its pricing power and cost economics. The operating margin of 22.30 and net profit margin of 17.10 provide insight into operational efficiency.
| Gross Margin | 68.75 |
| Operating Margin | 22.30 |
| Pretax Margin | 22.96 |
| Profit Margin | 17.10 |
| EBITDA Margin | 22.30 |
Stock Splits
J. B. Chemicals & Pharmaceuticals Limited's most recent stock split took place on September 18, 2023 with a 1:2 split ratio.
| Last Split Date | 9/18/2023 |
| Split Ratio | 1:2 |
Scores
J. B. Chemicals & Pharmaceuticals Limited posts an Altman Z-Score of 28.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 28.02 |